This is significant. The Class two limits had pushed patients toward unregulated grey-market resources. The reversal reopens the legit compounding pathway for peptides like thymosin alpha-1 and Other folks.Specified peptides have already been the topic of regulatory discussion about whether or not they can be compounded under federal regulation. Re